Evidence map›Paper›PMID 33827988›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.

Elijah L Mena, Callie J Donahue, Laura Pontano Vaites, Jie Li, Gergely Rona, Colin O'Leary, Luca Lignitto, Bearach Miwatani-Minter, Joao A Paulo, Avantika Dhabaria and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Structural insights into ORF10 recognition by ZYG11B.Biochemical and biophysical research communications · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Elijah L MenaDivision of Genetics, Department of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-9980-9018
Callie J DonahueDepartment of Microbiology, National Emerging Infectious Disease Laboratories, Boston University Medical Campus, Boston, MA 02118.ORCID 0000-0002-4284-2914
Laura Pontano VaitesDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
Jie LiDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.ORCID 0000-0003-2400-9790
Gergely RonaDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.ORCID 0000-0003-3222-7261
Colin O'LearyDivision of Genetics, Department of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Luca LignittoDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.ORCID 0000-0001-6164-1299
Bearach Miwatani-MinterDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.ORCID 0000-0003-1725-2020
Joao A PauloDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-4291-413X
Avantika DhabariaDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.
Beatrix UeberheideDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.
Steven P GygiDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
Michele PaganoDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016; Michele.Pagano@nyulangone.org wade_harper@hms.harvard.edu radavey@bu.edu selledge@genetics.med.harvard.edu.
J Wade HarperDepartment of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115; Michele.Pagano@nyulangone.org wade_harper@hms.harvard.edu radavey@bu.edu selledge@genetics.med.harvard.edu.ORCID 0000-0002-6944-7236
Robert A DaveyDepartment of Microbiology, National Emerging Infectious Disease Laboratories, Boston University Medical Campus, Boston, MA 02118; Michele.Pagano@nyulangone.org wade_harper@hms.harvard.edu radavey@bu.edu selledge@genetics.med.harvard.edu.
Stephen J ElledgeDivision of Genetics, Department of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; Michele.Pagano@nyulangone.org wade_harper@hms.harvard.edu radavey@bu.edu selledge@genetics.med.harvard.edu.ORCID 0000-0001-7923-6283
New York University · USHarvard University · USBrigham and Women's Hospital · USBoston University · USHoward Hughes Medical Institute · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Ubiquitin Mediated Proteolysis and Cell Cycle ControlR01AG011085 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JEFFREY W HARPER · 1993 to 2026
$10.9M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
Acquisition of an Orbitrap Elite Mass Spectrometer with ETDS10OD010582 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI UEBERHEIDE, BEATRIX MAGDALENA · 2013 to 2013
$600k
NCI NIH HHS P30 CA016087NIA NIH HHS R01 AG011085NIGMS NIH HHS R01 GM132129NIH HHS S10 OD010582
6 · The paper itself

Abstract

In order to understand the transmission and virulence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is necessary to understand the functions of each of the gene products encoded in the viral genome. One feature of the SARS-CoV-2 genome that is not present in related, common coronaviruses is ORF10, a putative 38-amino acid protein-coding gene. Proteomic studies found that ORF10 binds to an E3 ubiquitin ligase containing Cullin-2, Rbx1, Elongin B, Elongin C, and ZYG11B (CRL2

Indexed as

Open Reading FramesCell Cycle ProteinsCOVID-19Cullin ProteinsHEK293 CellsHumansMultiprotein ComplexesSARS-CoV-2Viral ProteinsCell Cycle ProteinsCUL2 protein, humanCullin ProteinsMultiprotein ComplexesViral ProteinsZYG11A protein, humanCUL2ORF10SARS-CoV-2ZER1ZYG11B

Identifiers

PMID33827988
PMCPMC8092598
OpenAlexW3149637542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.